(Q80726137)
Statements
Phase I pharmacokinetic study of the safety and tolerability of lapatinib (GW572016) in combination with oxaliplatin/fluorouracil/leucovorin (FOLFOX4) in patients with solid tumors (English)
Jos H Beijnen
Jan H M Schellens
Wandena S Siegel-Lakhai
Walter L Vervenne
Henk Boot
Marianne Keessen
Melissa Versola
Kevin M Koch
Deborah A Smith
Lini Pandite